UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

Annals of the rheumatic diseases, 2016-05, Vol.75 (5), p.795-810

2016

Volltextzugriff (PDF)

Tocilizumab use in pregnancy: analysis of a global safety database including data from clinical trials and post-marketing data

Seminars in arthritis and rheumatism, 2016-10, Vol.46 (2), p.238-245

2016

Volltextzugriff (PDF)

Mutations of the FHL1 Gene Cause Emery-Dreifuss Muscular Dystrophy

American journal of human genetics, 2009-09, Vol.85 (3), p.338-353

2009

Volltextzugriff (PDF)

Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity

PloS one, 2013-06, Vol.8 (6), p.e66637

2013

Volltextzugriff (PDF)

Paternal drug exposure

Reproductive toxicology (Elmsford, N.Y.), 2018-09, Vol.80, p.138-138

Hoeltzenbein, Maria

2018

Volltextzugriff (PDF)

Disruption of the Serine/Threonine Kinase 9 Gene Causes Severe X-Linked Infantile Spasms and Mental Retardation

American journal of human genetics, 2003-06, Vol.72 (6), p.1401-1411

2003

Volltextzugriff (PDF)

UBIAD1 mutation alters a mitochondrial prenyltransferase to cause Schnyder corneal dystrophy

PloS one, 2010-05, Vol.5 (5), p.e10760

2010

Volltextzugriff (PDF)

Ulipristal acetate and pregnancy outcome—an observational study

Human reproduction (Oxford), 2020-04, Vol.35 (4), p.751-758

2020

Volltextzugriff (PDF)

No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study

Rheumatology (Oxford, England), 2014-04, Vol.53 (4), p.757-763

2014

Volltextzugriff (PDF)

Neonatal effects of intrauterine metoprolol/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups

Journal of hypertension, 2020-02, Vol.38 (2), p.354-361

2020

Volltextzugriff (PDF)

Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide

Seizure (London, England), 2023-04, Vol.107, p.107-113

2023

Volltextzugriff (PDF)

Antiepileptic treatment with levetiracetam during the first trimester and pregnancy outcome: An observational study

Epilepsia (Copenhagen), 2024-01, Vol.65 (1), p.26-36

2024

Volltextzugriff (PDF)

How to account for early overly small risk sets in the analysis of pregnancy outcome data?—Comparison of different methods for stabilizing the Aalen‐Johansen estimator

Pharmacoepidemiology and drug safety, 2024-01, Vol.33 (1), p.e5718-n/a

2024

Volltextzugriff (PDF)

Ivabradine use in pregnant women—treatment indications and pregnancy outcome: an evaluation of the German Embryotox database

European journal of clinical pharmacology, 2021-07, Vol.77 (7), p.1029-1037

2021

Volltextzugriff (PDF)

Efficacy and safety of 2-drug regime dolutegravir/lamivudine in pregnancy and breastfeeding – clinical implications and perspectives

Journal of perinatal medicine, 2024-09

2024

Volltextzugriff (PDF)

Pregnancy Outcome After First Trimester Use of Methyldopa: A Prospective Cohort Study

Hypertension (Dallas, Tex. 1979), 2017-07, Vol.70 (1), p.201-208

2017

Volltextzugriff (PDF)

Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: an observational study

Journal of hypertension, 2020-01, Vol.38 (1), p.133-141

2020

Volltextzugriff (PDF)

Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services

American journal of medical genetics. Part A, 2012-03, Vol.158A (3), p.588-596

2012

Volltextzugriff (PDF)

Pregnancy outcome after first trimester exposure to bisoprolol: an observational cohort study

Journal of hypertension, 2018-10, Vol.36 (10), p.2109-2117

2018

Volltextzugriff (PDF)

Fatal pregnancy outcome of a woman with idiopathic pulmonary hypertension

Reproductive toxicology (Elmsford, N.Y.), 2017-09, Vol.72, p.215-216

2017

Volltextzugriff (PDF)

Why does renin-angiotensin system inhibitor exposure happen during later pregnancy despite warnings – an approach to the problem

Reproductive toxicology (Elmsford, N.Y.), 2019-09, Vol.88, p.129-130

2019

Volltextzugriff (PDF)

33 Lacosamide use during pregnancy – An evaluation of the German embryotox database

Reproductive toxicology (Elmsford, N.Y.), 2019-09, Vol.88, p.143-144

2019

Volltextzugriff (PDF)

Hereditary spastic paraplegia caused by mutations in the SPG4 gene

European journal of human genetics : EJHG, 2000-10, Vol.8 (10), p.771-776

2000

Volltextzugriff (PDF)

Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban – A case series from the German Embryotox Pharmacogivilance Centre

Reproductive toxicology (Elmsford, N.Y.), 2015-11, Vol.57, p.215-215

2015

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(63)

Publikationsform

Sprache

Englisch
(67)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(40)
Humans
(39)
Female
(29)
Biological And Medical Sciences
(20)
Pregnancy
(20)
Genetics & Heredity
(19)
Medical Sciences
(17)
Male
(15)
Pregnancy Outcome
(14)
Fundamental And Applied Biological Sciences. Psychology
(13)
Adult
(12)
Mutation
(11)
Medical Genetics
(10)
Phenotype
(10)
Spontaneous Abortion
(10)
Genetics Of Eukaryotes. Biological And Molecular Evolution
(9)
Child
(8)
Child, Preschool
(8)
Adolescent
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

Tocilizumab use in pregnancy: analysis of a global safety database including data from clinical trials and post-marketing data

Mutations of the FHL1 Gene Cause Emery-Dreifuss Muscular Dystrophy

Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity

Paternal drug exposure

Disruption of the Serine/Threonine Kinase 9 Gene Causes Severe X-Linked Infantile Spasms and Mental Retardation

UBIAD1 mutation alters a mitochondrial prenyltransferase to cause Schnyder corneal dystrophy

Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation

Ulipristal acetate and pregnancy outcome—an observational study

No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study

Neonatal effects of intrauterine metoprolol/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups

Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide

Antiepileptic treatment with levetiracetam during the first trimester and pregnancy outcome: An observational study

How to account for early overly small risk sets in the analysis of pregnancy outcome data?—Comparison of different methods for stabilizing the Aalen‐Johansen estimator

Ivabradine use in pregnant women—treatment indications and pregnancy outcome: an evaluation of the German Embryotox database

Efficacy and safety of 2-drug regime dolutegravir/lamivudine in pregnancy and breastfeeding – clinical implications and perspectives

Pregnancy Outcome After First Trimester Use of Methyldopa: A Prospective Cohort Study

Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: an observational study

Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services

Pregnancy outcome after first trimester exposure to bisoprolol: an observational cohort study

Fatal pregnancy outcome of a woman with idiopathic pulmonary hypertension

Why does renin-angiotensin system inhibitor exposure happen during later pregnancy despite warnings – an approach to the problem

33 Lacosamide use during pregnancy – An evaluation of the German embryotox database

Hereditary spastic paraplegia caused by mutations in the SPG4 gene

Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban – A case series from the German Embryotox Pharmacogivilance Centre

Suchergebnisse filtern